验证数据展示
经过测试的应用
Positive IF/ICC detected in | 5 µg/mL PHA ( 3 days) treated human PBMCs |
Positive FC detected in | 5 µg/mL PHA for 3 days human PBMCs |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:500-1:2000 |
Flow Cytometry (FC) | FC : 0.20 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
68893-3-Ig targets Integrin alpha-E in IF/ICC, FC, ELISA applications and shows reactivity with human samples.
经测试应用 | IF/ICC, FC, ELISA Application Description |
经测试反应性 | human |
免疫原 | Integrin alpha-E fusion protein Ag27410 种属同源性预测 |
宿主/亚型 | Mouse / IgG1 |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide) |
别名 | CD103, 4B6G6, Integrin alpha E, HUMINAE, HML-1 antigen |
计算分子量 | 1179 aa, 130 kDa |
GenBank蛋白编号 | BC113436 |
基因名称 | ITGAE |
Gene ID (NCBI) | 3682 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Protein G Magarose purification |
UNIPROT ID | P38570 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Integrin alpha-E (CD103) is a member of the integrin family, specifically the αEβ7 heterodimer. It plays a crucial role in the immune system, particularly in the interaction between leukocytes and epithelial cells. Integrin alpha-E (CD103) is a critical component of the immune system, particularly in the context of mucosal immunity. Its ability to bind to E-cadherin and regulate the production of IFN-I in cDCs during viral infections highlights its multifaceted role in immune regulation and disease prevention. (PMID: 33584680)
实验方案
Product Specific Protocols | |
---|---|
IF protocol for Integrin alpha-E antibody 68893-3-Ig | Download protocol |
FC protocol for Integrin alpha-E antibody 68893-3-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |